August 29, 2016 10:10 PM ET

Biotechnology

Company Overview of Juno Therapeutics Inc.

Executive Profile

Hans E. Bishop

Co-Founder, Chief Executive Officer, President and Director, Juno Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
52$5,299,326
As of Fiscal Year 2015

Background

Mr. Hans E. Bishop serves as the Chief Operating Officer of Photothera, a late stage medical device company. Mr. Bishop has more than 18 years of pharmaceutical industry experience. He is Co-founder of Juno Therapeutics Inc. and has been its its Chief Executive Officer since September 2013. He serves as the President of Juno Therapeutics Inc. He served as Consultant of Dendreon Corp. from October 1, 2011 to December 31, 2011. Mr. Bishop served as the Chief Operating ...

Corporate Headquarters

307 Westlake Avenue North
Seattle, Washington 98109

United States

Phone: 206-582-1600
Fax: --

Board Members Memberships

Director
2013-Present
Co-Founder, Chief Executive Officer, President and Director

Education

BS
Brunel University

Other Affiliations

Annual Compensation

Salary$425,000
Bonus$148,750
Total Annual Compensation$573,750

Stocks Options

Exercised Options$54,000
Exercised Options Value$2,125,456
Exercisable Options$285,220
Exercisable Options Value$9,739,899
Unexercisable Options$802,286
Unexercisable Options Value$25,895,801
Total Value of Options$37,761,156
Total Number of Options$1,141,506

Total Compensation

Total Annual Cash Compensation$850,000
Total Short Term Compensation$573,750
Total Calculated Compensation$5,299,326
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Randal J. Kirk J.D.Chairman and Chief Executive Officer
Intrexon Corporation
$4.4M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Juno Therapeutics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.